
Indoco Remedies Limited has informed the Exchange regarding a press release dated May 16, 2024, titled "USFDA successfully completes inspection at Indoco s API Kilo Lab manufacturing facility and IAS division without any observations".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated May 16, 2024, titled "USFDA successfully completes inspection at Indoco s API Kilo Lab manufacturing facility and IAS division without any observations".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies